Prevalence and features of fatty liver detected by physical examination in Guangzhou

World Journal of Gastroenterology

Volumn 19, Issue 32, 2013, Pages 5334-5339

  Liao, Xian Hua ^a   Cao, Xu ^a   Liu, Jie ^a   Xie, Xiao Hua ^a   Sun, Yan Hong ^a   Zhong, Bi Hui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Fatty liver; Hyperglycemia; Hyperlipidemia; Hypertension; Nonalcoholic; Prevalence

Indexed keywords

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ECHOGRAPHY; FATTY LIVER; FEMALE; GALLSTONE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; THORAX RADIOGRAPHY; ADOLESCENT; AGE; BLOOD; CHI SQUARE DISTRIBUTION; CHINA; COMORBIDITY; ELECTROCARDIOGRAPHY; HYPERGLYCEMIA; HYPERLIPIDEMIAS; LIVER; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; VERY ELDERLY; YOUNG ADULT;

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHINA; COMORBIDITY; ELECTROCARDIOGRAPHY; FATTY LIVER; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; HYPERURICEMIA; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; PREVALENCE; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84882945369     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i32.5334     Document Type: Article

References (27)

1. Jian-gao F. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Zhonghua Ganzangbing Zazhi 2010; 18: 163-166 [PMID: 20698076]
2. Fang JG, Zhu J, Li XJ, Li R, Dai F, Song XM, Chen L, Li F, Chen SY. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai]. Zhonghua Ganzangbing Zazhi 2005; 13: 83-88 [PMID: 15727689]
3. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777 [PMID: 17565629]
4. Liu LS. [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xinxueguanbing Zazhi 2011; 39: 579-615 [PMID: 22088239]
5. Chinese Medical Association Diabetes Branch. 2010 Chinese guidelines for the management of type 2 diabetes. Zhongguo Tangniaobing Zazhi 2012; 20: 87-117
6. Chinese Medical Association of Rheumatology. Guidelines for the diagnosis and management of primary gout. Zhonghua Fengshibingxue Zazhi 2004; 8: 178-181
7. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xinxueguanbing Zazhi 2007; 35: 390-419 [PMID: 17711682]
8. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x]
9. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003; 38: 954-961 [PMID: 14614602]
10. Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, Baijal R, Lala S, Chaudhary D, Deshpande A. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol 2007; 6: 161-163 [PMID: 17786142]
11. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395 [PMID: 15565570]
12. Shao GX, Zhang XG, Huang ZP, Zhu QY, Tang H. [Discussion on body mass index and fatty liver distribution from 28,384 patients in Shenzhen area]. Zhonghua Ganzangbing Zazhi 2003; 11: 372-373 [PMID: 12837226]
13. Zhang L, Xu LX, Zhu YQ. The prevalence of fatty liver and its correlation with other diseases in an adult population of Beijing. Zhongguo Xiandai Yisheng 2007; 45: 42-43
14. Frith J, Day CP, Henderson E, Burt AD, Newton JL. Nonalcoholic fatty liver disease in older people. Gerontology 2009; 55: 607-613 [PMID: 19690397 DOI: 10.1159/000235677]
15. Souza MR, Diniz Mde F, Medeiros-Filho JE, Araújo MS. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol 2012; 49: 89-96 [PMID: 22481692]
16. Arun J, Clements RH, Lazenby AJ, Leeth RR, Abrams GA. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg 2006; 16: 1351-1358 [PMID: 17059746]
17. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006; 26: 856-863 [PMID: 16911469]
18. Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. J Zhejiang Univ Sci B 2008; 9: 616-622 [PMID: 18763311 DOI: 10.1631/jzus. B0720016]
19. Kobayashi J, Maruyama T, Watanabe H, Kudoh A, Tateishi S, Sasaki T, Murano S, Watanabe M. Gender differences in the effect of type 2 diabetes on serum lipids, pre-heparin plasma lipoprotein lipase mass and other metabolic parameters in Japanese population. Diabetes Res Clin Pract 2003; 62: 39-45 [PMID: 14581156]
20. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002; 51: 2734-2741 [PMID: 12196466]
21. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007; 13: 6419-6424 [PMID: 18081233]
22. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005; 42: 5-13 [PMID: 15962320]
23. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-1218 [PMID: 17277038]
24. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007; 22: 293-303 [PMID: 17295757]
25. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000; 45: 1929-1934 [PMID: 11117562]
26. Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, Bolondi L. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004; 53: 1020-1023 [PMID: 15194655]
27. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609 [PMID: 22656328 DOI: 10.1053/j.gastro.2012.04.001]